BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37002176)

  • 1. Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?
    van Rees JM; Nordkamp S; Harmsen PW; Rutten H; Burger JWA; Verhoef C
    Eur J Surg Oncol; 2023 Sep; 49(9):106865. PubMed ID: 37002176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a history of metastases or synchronous metastases on survival in patients with locally recurrent rectal cancer.
    Voogt ELK; van Zoggel DMGI; Kusters M; Nieuwenhuijzen GAP; Cnossen JS; Creemers GJ; van Lijnschoten G; Nederend J; Roef MJ; Burger JWA; Rutten HJT
    Colorectal Dis; 2021 May; 23(5):1120-1131. PubMed ID: 33474793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of surgery for locally recurrent and second recurrent rectal cancer with metastatic disease.
    Tanaka A; Uehara K; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Surg Oncol; 2020 Dec; 35():328-335. PubMed ID: 32979698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts.
    van Geffen EGM; Langhout JMA; Hazen SJA; Sluckin TC; van Dieren S; Beets GL; Beets-Tan RGH; Borstlap WAA; Burger JWA; Horsthuis K; Intven MPW; Aalbers AGJ; Havenga K; Marinelli AWKS; Melenhorst J; Nederend J; Peulen HMU; Rutten HJT; Schreurs WH; Tuynman JB; Verhoef C; de Wilt JHW; Marijnen CAM; Tanis PJ; Kusters M; On Behalf Of The Dutch Snapshot Research Group
    Eur J Cancer; 2024 May; 202():114021. PubMed ID: 38520925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical relevance of indeterminate lung nodules in patients with locally recurrent rectal cancer.
    van Rees JM; Höppener DJ; Hagemans JAW; Rothbarth J; Grünhagen DJ; Nuyttens JJME; van Meerten E; de Vries M; Verhoef C
    Eur J Surg Oncol; 2021 Jul; 47(7):1616-1622. PubMed ID: 33446352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma.
    Hagemans JAW; Rothbarth J; van Bogerijen GHW; van Meerten E; Nuyttens JJME; Verhoef C; Burger JWA
    Ann Surg Oncol; 2019 Apr; 26(4):1134-1141. PubMed ID: 30725310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
    Swartjes H; van Rees JM; van Erning FN; Verheij M; Verhoef C; de Wilt JHW; Vissers PAJ; Koëter T
    Ann Surg Oncol; 2023 Jul; 30(7):3915-3924. PubMed ID: 36790731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
    Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
    Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
    Elliot AH; Othman BN; Suzuki C; Blomqvist L; Martling A; Johansson H; Glimelius B; Nilsson PJ; Iversen H
    Anticancer Res; 2021 May; 41(5):2459-2465. PubMed ID: 33952471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 13. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
    Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of an aggressive approach to resection of locally recurrent rectal cancer.
    Wells BJ; Stotland P; Ko MA; Al-Sukhni W; Wunder J; Ferguson P; Lipa J; Last L; Smith AJ; Swallow CJ
    Ann Surg Oncol; 2007 Feb; 14(2):390-5. PubMed ID: 17063304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Holm T; Martling A
    Br J Surg; 2019 May; 106(6):790-798. PubMed ID: 30776087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related differences in morbidity and mortality after surgery for primary clinical T4 and locally recurrent rectal cancer.
    Ketelaers SHJ; Voogt ELK; Simkens GA; Bloemen JG; Nieuwenhuijzen GAP; de Hingh IHJ; Rutten HJT; Burger JWA; Orsini RG
    Colorectal Dis; 2021 May; 23(5):1141-1152. PubMed ID: 33492750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area.
    Alberda WJ; Haberkorn BC; Morshuis WG; Oudendijk JF; Nuyttens JJ; Burger JW; Verhoef C; van Meerten E
    Int J Colorectal Dis; 2015 Aug; 30(8):1075-80. PubMed ID: 26077667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the location of local rectal cancer recurrence and predictors of survival.
    Du P; Burke JP; Khoury W; Lavery IC; Kiran RP; Remzi FH; Dietz DW
    Int J Colorectal Dis; 2016 Apr; 31(4):825-32. PubMed ID: 26861707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.